Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 28


Depression symptom dimensions as predictors of antidepressant treatment outcome: replicable evidence for interest-activity symptoms.

Uher R, Perlis RH, Henigsberg N, Zobel A, Rietschel M, Mors O, Hauser J, Dernovsek MZ, Souery D, Bajs M, Maier W, Aitchison KJ, Farmer A, McGuffin P.

Psychol Med. 2012 May;42(5):967-80. doi: 10.1017/S0033291711001905. Epub 2011 Sep 20.


Translating biomarkers to clinical practice.

Perlis RH.

Mol Psychiatry. 2011 Nov;16(11):1076-87. doi: 10.1038/mp.2011.63. Epub 2011 Jun 28. Review.


Genes, environment, and individual differences in responding to treatment for depression.

Uher R.

Harv Rev Psychiatry. 2011 May-Jun;19(3):109-24. doi: 10.3109/10673229.2011.586551. Review.


Melancholic, atypical and anxious depression subtypes and outcome of treatment with escitalopram and nortriptyline.

Uher R, Dernovsek MZ, Mors O, Hauser J, Souery D, Zobel A, Maier W, Henigsberg N, Kalember P, Rietschel M, Placentino A, Mendlewicz J, Aitchison KJ, McGuffin P, Farmer A.

J Affect Disord. 2011 Jul;132(1-2):112-20. doi: 10.1016/j.jad.2011.02.014. Epub 2011 Mar 15.


On responder analyses when a continuous variable is dichotomized and measurement error is present.

Kunz M.

Biom J. 2011 Feb;53(1):137-55. doi: 10.1002/bimj.201000069.


Personalized medicine for depression: can we match patients with treatments?

Simon GE, Perlis RH.

Am J Psychiatry. 2010 Dec;167(12):1445-55. doi: 10.1176/appi.ajp.2010.09111680. Epub 2010 Sep 15. Review.


Efficacy of antidepressants: a re-analysis and re-interpretation of the Kirsch data.

Fountoulakis KN, Möller HJ.

Int J Neuropsychopharmacol. 2011 Apr;14(3):405-12. doi: 10.1017/S1461145710000957. Epub 2010 Aug 27. Review.


Genome-wide pharmacogenetics of antidepressant response in the GENDEP project.

Uher R, Perroud N, Ng MY, Hauser J, Henigsberg N, Maier W, Mors O, Placentino A, Rietschel M, Souery D, Zagar T, Czerski PM, Jerman B, Larsen ER, Schulze TG, Zobel A, Cohen-Woods S, Pirlo K, Butler AW, Muglia P, Barnes MR, Lathrop M, Farmer A, Breen G, Aitchison KJ, Craig I, Lewis CM, McGuffin P.

Am J Psychiatry. 2010 May;167(5):555-64. doi: 10.1176/appi.ajp.2009.09070932. Epub 2010 Apr 1.


Antidepressant drug effects and depression severity: a patient-level meta-analysis.

Fournier JC, DeRubeis RJ, Hollon SD, Dimidjian S, Amsterdam JD, Shelton RC, Fawcett J.

JAMA. 2010 Jan 6;303(1):47-53. doi: 10.1001/jama.2009.1943. Review.


A genomewide association study of citalopram response in major depressive disorder.

Garriock HA, Kraft JB, Shyn SI, Peters EJ, Yokoyama JS, Jenkins GD, Reinalda MS, Slager SL, McGrath PJ, Hamilton SP.

Biol Psychiatry. 2010 Jan 15;67(2):133-8. doi: 10.1016/j.biopsych.2009.08.029. Epub .


A genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depression.

Ising M, Lucae S, Binder EB, Bettecken T, Uhr M, Ripke S, Kohli MA, Hennings JM, Horstmann S, Kloiber S, Menke A, Bondy B, Rupprecht R, Domschke K, Baune BT, Arolt V, Rush AJ, Holsboer F, Müller-Myhsok B.

Arch Gen Psychiatry. 2009 Sep;66(9):966-75. doi: 10.1001/archgenpsychiatry.2009.95.


Common polygenic variation contributes to risk of schizophrenia and bipolar disorder.

International Schizophrenia Consortium, Purcell SM, Wray NR, Stone JL, Visscher PM, O'Donovan MC, Sullivan PF, Sklar P.

Nature. 2009 Aug 6;460(7256):748-52. doi: 10.1038/nature08185. Epub 2009 Jul 1.


Harnessing the information contained within genome-wide association studies to improve individual prediction of complex disease risk.

Evans DM, Visscher PM, Wray NR.

Hum Mol Genet. 2009 Sep 15;18(18):3525-31. doi: 10.1093/hmg/ddp295. Epub 2009 Jun 24.


When is pharmacogenetic testing for antidepressant response ready for the clinic? A cost-effectiveness analysis based on data from the STAR*D study.

Perlis RH, Patrick A, Smoller JW, Wang PS.

Neuropsychopharmacology. 2009 Sep;34(10):2227-36. doi: 10.1038/npp.2009.50. Epub 2009 Jun 3.


Differential efficacy of escitalopram and nortriptyline on dimensional measures of depression.

Uher R, Maier W, Hauser J, Marusic A, Schmael C, Mors O, Henigsberg N, Souery D, Placentino A, Rietschel M, Zobel A, Dmitrzak-Weglarz M, Petrovic A, Jorgensen L, Kalember P, Giovannini C, Barreto M, Elkin A, Landau S, Farmer A, Aitchison KJ, McGuffin P.

Br J Psychiatry. 2009 Mar;194(3):252-9. doi: 10.1192/bjp.bp.108.057554. Erratum in: Br J Psychiatry. 2009 Jul;195(1):87.


Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration.

Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ, Johnson BT.

PLoS Med. 2008 Feb;5(2):e45. doi: 10.1371/journal.pmed.0050045.


Measuring depression: comparison and integration of three scales in the GENDEP study.

Uher R, Farmer A, Maier W, Rietschel M, Hauser J, Marusic A, Mors O, Elkin A, Williamson RJ, Schmael C, Henigsberg N, Perez J, Mendlewicz J, Janzing JG, Zobel A, Skibinska M, Kozel D, Stamp AS, Bajs M, Placentino A, Barreto M, McGuffin P, Aitchison KJ.

Psychol Med. 2008 Feb;38(2):289-300. Epub 2007 Oct 9.


Temperament, character and personality disorders as predictors of response to interpersonal psychotherapy and cognitive-behavioural therapy for depression.

Joyce PR, McKenzie JM, Carter JD, Rae AM, Luty SE, Frampton CM, Mulder RT.

Br J Psychiatry. 2007 Jun;190:503-8.


The Montgomery Asberg and the Hamilton ratings of depression: a comparison of measures.

Carmody TJ, Rush AJ, Bernstein I, Warden D, Brannan S, Burnham D, Woo A, Trivedi MH.

Eur Neuropsychopharmacol. 2006 Dec;16(8):601-11. Epub 2006 Jun 12.


The cost of dichotomising continuous variables.

Altman DG, Royston P.

BMJ. 2006 May 6;332(7549):1080. Review. No abstract available.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk